Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
Ebiomedicine|October 15, 2023
Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [<sup>18</sup>F]Florzolotau PET imaging and subtype/stage inference algorithmJimin Hong, Jiaying Lu, Fengtao Liu, et al.
Nature Communications|July 10, 2025
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer's diseaseYing Luan, Weiyi Wang, Qi Huang, et al.
NPJ Precision Oncology|November 25, 2024
Deep mutual learning on hybrid amino acid PET predicts H3K27M mutations in midline gliomasYifan Yuan, Guanglei Li, Shuhao Mei, et al.
ACS Chemical Neuroscience|May 22, 2024
Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [<sup>18</sup>F]GSK1482160Yanyan Kong, Lei Cao, Jiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2025
Choroid plexus free-water correlates with glymphatic function in Alzheimer's diseaseXiaomeng Xu, Xinyuan Yang, Junfang Zhang, et al.
Frontiers in Cell and Developmental Biology|July 19, 2021
The Synaptic Vesicle Protein 2A Interacts With Key Pathogenic Factors in Alzheimer's Disease: Implications for TreatmentYanyan Kong, Lin Huang, Weihao Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2023
Dopaminergic damage pattern predicts phenoconversion time in isolated rapid eye movement sleep behavior disorderShuang Feng, Jingjie Ge, Shujun Zhao, et al.
The Journal of Biological Chemistry|May 29, 2025
Secreted EMC10 inhibits muscle GLUT4 activity and glucose uptake in miceShuoshuo Jin, Wei Wu, Shan Liu, et al.
European Radiology|April 26, 2023
Feasibility of <sup>18</sup>F-florzolotau quantification in patients with Alzheimer's disease based on an MRI-free tau PET templateJiaying Lu, Zizhao Ju, Min Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 18, 2024
Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairmentJie Wang, Qi Huang, Kun He, et al.
Pageof 20